Company Name: ImmunoGen, Inc.    

ImmunoGen, Inc. is a biotechnology company.  The company is engaged in the development of targeted therapeutics for cancer utilizing its antibody-drug conjugate (ADC) technology.

Ticker Symbol: IMGN (NASDAQ)

Company Website: www.immunogen.com

Social Media:

ImmunoGen LinkedIn

ImmunoGen Twitter

Headquarters: Waltham, MA